Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma-Reference-Cited by-同舟云学术

Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma

Published:2015-07 Issue:28 Volume:94 Page:e1142
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Andersen Kim Francis,Fuglo Hanna Maria,Rasmussen Sine Hvid,Petersen Michael Mork,Loft Annika

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference32 articles.

1. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group.;Coindre;Cancer,2001

2. Sarcoma.;Skubitz;Mayo Clin Proc,2007

3. Cancer statistics, 2012.;Siegel;CA Cancer J Clin,2012

4. Utilization of positron emission tomography in the management of patients with sarcoma.;Benz;Curr Opin Oncol,2009

5. Molecular imaging of cancer with positron emission tomography.;Gambhir;Nat Rev Cancer,2002

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of [18F]FDG PET metabolic parameters in osteosarcoma and Ewing’s sarcoma: a systematic review and network meta-analysis;Clinical and Translational Imaging;2024-05-13

2. Prognostic significance of [18F]FDG PET metabolic parameters in adults and children with soft-tissue sarcoma: a meta-analysis;Clinical and Translational Imaging;2024-02-27

3. Prognostic Value of Pre-Treatment [18F]FDG PET/CT Texture Analysis in Undifferentiated Soft-Tissue Sarcoma;Journal of Clinical Medicine;2022-12-29

4. PET-CT in the Evaluation of Neoadjuvant/Adjuvant Treatment Response of Soft-tissue Sarcomas;JBJS Reviews;2022-12

5. An evaluation of the response to neoadjuvant chemotherapy for osteosarcoma of extremities: PERCIST versus RECIST 1.1 criteria after long-term follow-up;Annals of Nuclear Medicine;2022-04-05